The Drug Enforcement Administration has increased the production limit of Vyvanse, an ADHD drug made by Takeda Pharmaceutical, and its generic versions by 24% to address an ongoing shortage of the medicines in the U.S.
The Latest
Individuals without previous mental health concerns taking weight loss medication semaglutide did not have a higher risk of depressive symptoms, suicidal thoughts or behaviors, a study published in JAMA Internal Medicine found.
Sen. Ron Wyden says he is "hard at work" drafting legislation to regulate residential behavioral treatment facilities.
Several mental health treatment sites have closed or shared plans to close in the last month.
Baton Rouge, La.-based Woman’s Hospital opened the state's first perinatal mental health unit.
VA Fargo (N.D.) Health Care is set to break ground Sept. 6 on an outpatient mental wellness and recovery facility, the Minot Daily News reported Sept. 3.
The National Institute of Health will fund a $20 million study following people with mental illness over five years.
A small proportion of people with substance use disorders believe they need treatment, according to the National Survey on Drug Use and Health.
Acadia Healthcare, a behavioral health system spanning 38 states, allegedly steers patients to its facilities and delays discharges to increase profits, according to an investigation from The New York Times.
Rates of mental health issues and conditions are on the rise among Americans of all demographics, and women are no exception.